BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 106.57 USD 1.57% Market Closed
Market Cap: 25.6B USD

Relative Value

The Relative Value of one BNTX stock under the Base Case scenario is hidden USD. Compared to the current market price of 106.57 USD, BioNTech SE is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BNTX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
23
vs Industry
48
Median 3Y
3.7
Median 5Y
3.7
Industry
7.2
Forward
10.7
vs History
vs Industry
1
Median 3Y
3.3
Median 5Y
3.4
Industry
23.2
Forward
-17.2
vs History
4
vs Industry
2
Median 3Y
4
Median 5Y
3.7
Industry
19.3
vs History
vs Industry
11
Median 3Y
4
Median 5Y
3.2
Industry
22.5
vs History
77
vs Industry
57
Median 3Y
1.2
Median 5Y
1.8
Industry
2.7
vs History
33
vs Industry
66
Median 3Y
1.3
Median 5Y
1.3
Industry
7.5
Forward
2.6
vs History
34
vs Industry
67
Median 3Y
1.5
Median 5Y
1.6
Industry
9.4
vs History
vs Industry
12
Median 3Y
1.4
Median 5Y
1.7
Industry
4.6
Forward
-3.5
vs History
vs Industry
11
Median 3Y
1.4
Median 5Y
1.4
Industry
4.5
Forward
-3
vs History
14
vs Industry
6
Median 3Y
1.6
Median 5Y
1.2
Industry
4.9
vs History
vs Industry
17
Median 3Y
1.3
Median 5Y
1
Industry
3.7
vs History
80
vs Industry
56
Median 3Y
1.4
Median 5Y
2.2
Industry
4.9

Multiples Across Competitors

BNTX Competitors Multiples
BioNTech SE Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
BioNTech SE
NASDAQ:BNTX
25.6B USD 8 -33.1 -6.4 -4.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 202 723.3 -162 560.5 -197 400.3 -195 147.7
US
Abbvie Inc
NYSE:ABBV
337.5B USD 5.9 81.2 15.4 22.8
US
Amgen Inc
NASDAQ:AMGN
158.7B USD 4.7 26.8 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
136.9B USD 4.8 23 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 10.5 -118.3 25.2 26.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 059.8 -525.6 -572.3 -557.1
AU
CSL Ltd
ASX:CSL
115.7B AUD 4.9 27.3 16.9 21.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
57.3B USD 4.1 12.7 11.3 12.7
US
Seagen Inc
F:SGT
39.3B EUR 19.8 -60.8 -65.6 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.1B USD 17.1 -148.8 -666.4 -333.9
P/S Multiple
Revenue Growth P/S to Growth
DE
BioNTech SE
NASDAQ:BNTX
Average P/S: 3 109 533
8
-7%
N/A
FR
Pharnext SCA
OTC:PNEXF
34 202 723.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.5
10%
1.1
US
E
Epizyme Inc
F:EPE
2 059.8
N/A N/A
AU
CSL Ltd
ASX:CSL
4.9
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.1
4%
1
US
S
Seagen Inc
F:SGT
19.8
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.1
29%
0.6
P/E Multiple
Earnings Growth PEG
DE
BioNTech SE
NASDAQ:BNTX
Average P/E: 34.2
Negative Multiple: -33.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 560.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.2
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118.3 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.6 N/A N/A
AU
CSL Ltd
ASX:CSL
27.3
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.7
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -148.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
BioNTech SE
NASDAQ:BNTX
Average EV/EBITDA: 15.5
Negative Multiple: -6.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 400.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.3 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.3
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -666.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DE
BioNTech SE
NASDAQ:BNTX
Average EV/EBIT: 20.1
Negative Multiple: -4.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 147.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.1 N/A N/A
AU
CSL Ltd
ASX:CSL
21.1
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.7
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -333.9 N/A N/A